Back
Controladora Vuela Compania de Aviacion SAB de CV 10K Form
Buy
57
VLRS
Controladora Vuela Compania de Aviacion SAB de CV
Last Price:
8.59
Seasonality Move:
10.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VLRS News And Ratings
See the #1 stock for the next 7 days that we like better than VLRS
VLRS Financial Statistics
Sales & Book Value
Annual Sales: | $3.26B |
---|---|
Cash Flow: | $245M |
Price / Cash Flow: | 1.31 |
Annual Sales: | $2.41 |
Price / Book: | 3.58 |
Profitability
EPS (TTM): | 1.00000 |
---|---|
Net Income (TTM): | $112M |
Gross Margin: | $506M |
Return on Equity: | 56.74% |
Return on Assets: | 2.24% |
Controladora Vuela Compania de Aviacion SAB de CV Earnings Forecast
Key Controladora Vuela Compania de Aviacion SAB de CV Financial Ratios
- The Gross Profit Margin over the past 14 years for VLRS is 15.53%.
- The Selling, General & Administrative Expenses for VLRS have been equal to 5.12% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 2,737.50% of Operating Income.
- The Net Earning history of VLRS is 0.25% of Total Revenues.
- Per Share Earnings over the last 14 years have been positive in 8 years.
Controladora Vuela Compania de Aviacion SAB de CV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Passenger Airlines |
Sector: | Industrials |
Current Symbol: | VLRS |
CUSIP: | 21240E |
Website: | volaris.com |
Debt
Debt-to-Equity Ratio: | 2.32 |
---|---|
Current Ratio: | 0.73 |
Quick Ratio: | 0.6 |
Price-to-Earnings
Trailing P/E Ratio: | 123.14 |
---|---|
Forward P/E Ratio: | 13.42 |
VLRS Technical Analysis vs Fundamental Analysis
Buy
57
Controladora Vuela Compania de Aviacion SAB de CV (VLRS)
is a Buy
Is Controladora Vuela Compania de Aviacion SAB de CV a Buy or a Sell?
-
Controladora Vuela Compania de Aviacion SAB de CV stock is rated a Buy
The current Controladora Vuela Compania de Aviacion SAB de CV [VLRS] share price is $8.62. The Score for VLRS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.